Echographic evidence of regression of a periocular infantile capillary hemangioma treated with systemic propranolol.

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

This article documents quantitative changes in the size of a periocular capillary hemangioma using sequential echographic testing in a patient receiving off-label treatment with systemic propranolol therapy. The patient presented at 7 weeks old with a right periocular capillary hemangioma. Systemic propranolol therapy was elected. Diagnostic B-scan and quantitative A-scan echography documented the lesion size at presentation as 22.3 mm in greatest dimension. The tumor decreased in size to 20.0 mm after 21/2 weeks of treatment and 16.0 mm after 61/2 weeks of treatment. No adverse side effects have been noted. Echography is an excellent modality for documenting the regression of periocular capillary hemangiomas during treatment with systemic propranolol.

Original languageEnglish (US)
Pages (from-to)e18-21
JournalOphthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye
Volume42 Online
StatePublished - May 16 2011

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Fingerprint Dive into the research topics of 'Echographic evidence of regression of a periocular infantile capillary hemangioma treated with systemic propranolol.'. Together they form a unique fingerprint.

  • Cite this